Financial Performance - In 2025, the company achieved an operating revenue of RMB 2,762.2 million, representing a year-on-year increase of 5.1% compared to RMB 2,627.8 million in 2024[10] - The net profit attributable to shareholders was RMB 68.3 million, a decrease of 55.4% from RMB 153.2 million in 2024[10] - Basic earnings per share were RMB 0.03, down from RMB 0.07 in 2024[10] - Gross profit for the same period was approximately RMB 396.4 million, a decrease of 7.9% year-on-year[17] - The logistics and supply chain services segment generated revenue of approximately RMB 2,057.1 million, a year-on-year increase of 5.8%[20] - The supply chain financial services segment reported revenue of approximately RMB 445.4 million, a decrease of 3.9% compared to the previous year[20] - The IoT and data services segment achieved revenue of approximately RMB 259.7 million, reflecting a year-on-year increase of 17.9%[20] - The company’s revenue for the year ended December 31, 2025, was approximately RMB 2,762.2 million, an increase of 5.1% compared to 2024[17] - The gross profit margin for the supply chain finance services segment decreased from 53.5% to 45.7%, attributed to increased competition and higher business policy costs[63] - Pre-tax profit fell by 53.2% from RMB 199.2 million in 2024 to RMB 93.2 million in 2025, attributed to increased competition and higher business costs[78] - Net profit for the year dropped to approximately RMB 59.6 million in 2025 from RMB 156.7 million in 2024, resulting in a net profit margin of 2.2% compared to 6.0% in the previous year[80] Market and Sales Performance - The commercial vehicle market in 2025 saw a total sales volume of 4,296 thousand units, with a year-on-year growth of 10.9%[9] - Domestic sales of commercial vehicles reached 3,236 thousand units, growing by 9.0% year-on-year, while exports increased by 17.2% to 1,060 thousand units[9] - The company sold 1,719 commercial vehicles in 2025, including 1,103 new energy vehicles, with new energy sales increasing by 241.5% year-on-year[22] - The top five customers accounted for approximately 25.7% of total revenue for the year ending December 31, 2025, compared to 42.0% for the year ending December 31, 2024[169] - The largest single customer contributed about 14.6% of total revenue for the year ending December 31, 2025, up from 11.1% for the year ending December 31, 2024[169] Financing and Investment Activities - The company issued asset-backed securities (ABS) totaling RMB 1,130 million in its financing leasing business[12] - The financing lease business added a new investment amount of RMB 6,235.4 million in 2025, with 10,703 new financing lease agreements signed[24] - The company expanded its factoring business with a new investment amount of RMB 2,297.6 million for 2025[25] - The company issued two tranches of asset-backed securities (ABS) totaling RMB 1,130 million in 2025 to diversify its funding sources[25] - The company has utilized RMB 101.1 million for general working capital, which has been fully used[164] - The company has allocated RMB 303.3 million for enhancing core technology capabilities in the Internet of Vehicles and data services, with RMB 105.2 million already utilized[164] Assets and Liabilities - Total assets as of December 31, 2025, were RMB 11,428.0 million, an increase from RMB 9,489.2 million in 2024[19] - Total liabilities increased to RMB 8,087.4 million as of December 31, 2025, compared to RMB 6,130.7 million in 2024[19] - As of December 31, 2025, the total financing lease receivables amounted to RMB 7,718.7 million, an increase from RMB 6,260.7 million in 2024[36] - The total factoring receivables as of December 31, 2025, were RMB 1,335.2 million, compared to RMB 1,256.4 million in 2024[39] - Current assets increased from approximately RMB 7,015.8 million as of December 31, 2024, to approximately RMB 8,017.1 million as of December 31, 2025, primarily due to an increase of about RMB 1,317.8 million in inventory, trade receivables, and other receivables[81] Operational Efficiency and Cost Management - Total costs increased by approximately 7.7% from RMB 2,197.2 million in the year ending December 31, 2024, to RMB 2,365.8 million in the year ending December 31, 2025, mainly due to increased revenue[62] - The cost of the logistics and supply chain services segment increased by approximately 6.0%, aligning closely with a 5.8% increase in revenue for the same segment[62] - The gross profit decreased by 7.9% from RMB 430.6 million in the year ending December 31, 2024, to RMB 396.4 million in the year ending December 31, 2025, with the gross margin declining from 16.4% to 14.3%[63] - Administrative expenses decreased from RMB 127.7 million in 2024 to RMB 109.8 million in 2025, a reduction of approximately RMB 17.9 million, primarily due to lower consulting fees and office rent[68] - R&D expenses increased by 17.6% from RMB 34.2 million in 2024 to RMB 40.2 million in 2025, driven by an increase in self-developed projects and employee benefits[70] Governance and Management - Zhao Peng appointed as Executive Director and General Manager, responsible for overall management and operations since January 2025[126] - The management team has extensive experience in finance, operations, and strategic planning, enhancing the company's decision-making capabilities[126][134] - The company emphasizes the importance of independent directors in governance and oversight roles[129][130][133] - The board includes members with diverse backgrounds in finance, engineering, and management, contributing to a well-rounded governance structure[129][130][133] - The company has appointed new non-executive directors to strengthen its strategic planning and decision-making capabilities, enhancing governance and oversight[136] Future Plans and Strategic Initiatives - The company plans to enhance its core competitiveness by upgrading its product service matrix and transitioning from "sales and financing collaboration" to "production, sales, and service collaboration" in 2026[45] - The company aims to build a data, finance, logistics, and vehicle ecosystem brand matrix in 2026, enhancing its influence and customer trust through collaborative partnerships[49] - The company will launch the "De Yi Tong Tu" used car business in 2026 to boost vehicle sales, leveraging its core advantages in brand, technology, and service[48] - The company is actively pursuing opportunities for mergers and acquisitions to enhance its market position and expand its service offerings[149] Risk Management - The company has implemented risk management policies to address various operational risks and is committed to adjusting these policies as the business evolves[158] - The company has established credit policies to monitor credit risk exposure related to cash, cash equivalents, and trade receivables, ensuring that credit quality is assessed based on customer financial status and market conditions[118] - The company faces various market risks, including cash flow and fair value interest rate risks, with a potential impact of RMB 0.6 million on after-tax profit if interest rates on cash and cash equivalents rise or fall by 10%[116] Shareholder Information - The proposed final dividend for the fiscal year ending December 31, 2025, is RMB 0.3147 per 10 shares, to be distributed on August 26, 2026[150] - As of December 31, 2025, Shaanxi Automobile Group held approximately 68.77% of the company's shares[178] - The company has a reserve of approximately RMB 386.0 million available for distribution to shareholders as of December 31, 2025[168]

Financial Performance - The company's total revenue for the year ended December 31, 2025, was RMB 92,374,000, an increase from RMB 84,460,000 in 2024, representing a growth of approximately 9.4%[5] - Gross profit for the same period was RMB 24,307,000, slightly down from RMB 25,068,000 in the previous year, indicating a decrease of about 3.0%[5] - The net profit for the year was RMB 1,324,000, a significant decline from RMB 9,868,000 in 2024, reflecting a decrease of approximately 86.6%[6] - The company reported other comprehensive income of RMB 4,085,000, which was not present in the previous year, contributing to a total comprehensive income of RMB 5,409,000[6] - Administrative expenses increased to RMB 20,372,000 from RMB 14,555,000, marking a rise of approximately 40.0%[5] - The basic earnings per share for the year was RMB 2.32, compared to a loss of RMB 2.17 in the previous year[5] - The company reported a total equity of RMB 54.414 billion, reflecting a strong financial position[7] - The company’s total liabilities were RMB 190.775 billion, highlighting the leverage used in its capital structure[7] Asset Management - Total assets amounted to RMB 188.627 billion, with a net asset value of RMB 164.875 billion[7] - Non-current assets included property, plant, and equipment valued at RMB 17.087 billion, while investment properties were RMB 7.000 billion[7] - Current assets included cash and cash equivalents of RMB 38.317 billion and trade receivables of RMB 22.913 billion[7] - The company is focused on optimizing its asset utilization, as indicated by the substantial investment in property and equipment[7] Cash Flow and Financial Strategy - The company’s cash flow management is evident with a significant cash balance of RMB 38.317 billion[7] - The company’s financial strategy includes maintaining a healthy current ratio, supported by current assets exceeding current liabilities[7] - Operating cash flow increased to $6,391 million from $4,095 million, representing a growth of 56%[20] - Net cash provided by operating activities reached $4,506 million, up from $3,421 million, indicating a year-over-year increase of 32%[20] - The company reported a net cash flow from investment activities of 2,488,000 RMB, a decrease of 107,203,000 RMB compared to the previous year[21] Revenue Recognition and Contracts - Revenue is recognized when control of the goods or services is transferred to the customer, based on the completion of performance obligations[44] - The company expects to maintain a consistent revenue recognition policy based on the transfer of control of goods and services to customers, typically at the point of delivery[151] - The company’s sales contracts stipulate that revenue is recognized when control of the goods is transferred to the customer, aligning with industry practices of 30 to 90 days credit terms[152] Taxation and Deferred Tax - The company reported a current tax expense of RMB 1,981,000 for the year ending December 31, 2025, compared to RMB 726,000 in the previous year, reflecting a significant increase[164] - The deferred tax expense for the year was RMB (103,000), contrasting with a deferred tax benefit of RMB (1,600,000) in 2024, indicating a shift in tax position[164] - The company recognized a deferred tax asset of RMB 1,405 million from prior years, contributing to its overall tax strategy[165] Segment Performance - The total revenue for the group reached RMB 84,460,000, with contributions from various segments including RMB 22,823,000 from firefighting equipment and RMB 35,122,000 from aquatic products[140] - The firefighting equipment segment recorded a loss of RMB 4,186,000, while the aquatic products segment achieved a profit of RMB 6,388,000[140] - The company’s segment performance showed a total segment profit of RMB 6,167 million, with firefighting equipment and water-related products being the most profitable segments[146] Impairment and Goodwill - The company recognized a loss of RMB 1,891,000 related to goodwill impairment in 2025, indicating challenges in asset valuation[160] - The company must conduct impairment tests for cash-generating units annually or more frequently if there are indicators of potential impairment[42] - Goodwill arising from business combinations is recognized at cost less any accumulated impairment losses[41] Investment Properties and Fair Value - The company recognizes investment properties at cost, including any directly attributable expenditures, and subsequently measures them at fair value[76] - The fair value measurement of investment properties is classified as Level 3 in the fair value hierarchy[182] - The estimated fair value of industrial properties is based on a market unit sales rate of RMB 3,800 per square meter[181] Employee Compensation - Employee costs, including directors' remuneration, totaled RMB 7,299,000 for 2025, down from RMB 10,267,000 in 2024, indicating a decrease of 29.3%[162] - The total compensation for directors, executives, and supervisors for the year ending December 31, 2025, amounted to RMB 372 million, including salaries and bonuses[166] Future Strategies - Future strategies may include exploring new markets and enhancing product offerings to drive revenue growth[5] - The company plans to expand its market presence and enhance its product offerings in the upcoming fiscal year[23] - The company is focusing on developing new technologies and products to improve its competitive edge in the market[23]

Financial Performance - For the year ended December 31, 2025, Tianqi Lithium Corporation reported revenue of RMB 10,322,472,000, a decrease of 20.8% from RMB 13,029,739,000 in 2024[8] - Gross profit for the same period was RMB 4,058,448,000, down 32.4% from RMB 5,991,309,000 in 2024[8] - The company achieved a profit for the year of RMB 2,998,439,000, compared to a loss of RMB 880,378,000 in 2024, marking a significant turnaround[8] - Basic earnings per share for 2025 was RMB 0.28, recovering from a loss per share of RMB 5.32 in the previous year[8] - The company reported a total comprehensive income of RMB 3,155,923,000 for the year, compared to a loss of RMB 811,590,000 in 2024[11] - Profit before taxation for 2025 reached RMB 3,965,219,000, a significant increase from RMB 419,922,000 in 2024[79] - Actual tax expense for 2025 was RMB 966,780,000, compared to RMB 1,300,300,000 in 2024, indicating a reduction in tax burden[79] - Basic earnings attributable to equity shareholders for 2025 were RMB 458,430,000, a recovery from a loss of RMB 8,727,021,000 in 2024[91] Assets and Liabilities - Non-current assets increased to RMB 61,106,080,000 in 2025 from RMB 56,726,366,000 in 2024, reflecting a growth of 7.5%[14] - Total assets less current liabilities reached RMB 68,698,106,000, an increase from RMB 64,515,307,000 in 2024, showing a growth of 3.4%[14] - Non-current liabilities increased from RMB 14,454,259 thousand in 2024 to RMB 15,948,122 thousand in 2025, representing a growth of approximately 10.3%[17] - Net assets rose to RMB 52,749,984 thousand in 2025, up from RMB 50,061,048 thousand in 2024, indicating an increase of about 5.4%[17] - Total equity attributable to equity shareholders of the Company increased from RMB 42,771,217 thousand in 2024 to RMB 43,220,250 thousand in 2025, reflecting a growth of approximately 1.05%[17] - Non-controlling interests grew significantly from RMB 7,289,831 thousand in 2024 to RMB 9,529,734 thousand in 2025, marking an increase of around 30.7%[17] Revenue Breakdown - The Group's revenue from sales of lithium compounds and derivatives was RMB 5,699,074,000 in 2025, down from RMB 8,055,971,000 in 2024, representing a decrease of approximately 29.3%[41] - Revenue from sales of lithium concentrates was RMB 4,623,398,000 in 2025, compared to RMB 4,973,768,000 in 2024, indicating a decline of about 7.0%[41] - Total revenue from contracts with customers for the Group was RMB 10,322,472,000 in 2025, down from RMB 13,029,739,000 in 2024, reflecting a decrease of approximately 20.8%[41] Research and Development - Research and development costs slightly increased to RMB 47,593,000 from RMB 43,621,000, indicating continued investment in innovation[8] - Research and development expenses increased to RMB 47,593 in 2025 from RMB 43,621 in 2024, reflecting a growth of 9.0%[77] Cash Flow and Liquidity - Cash and cash equivalents decreased to RMB 3,745,939,000 from RMB 5,635,127,000, a decline of 33.5%[14] - Cash and bank balance decreased to RMB 3,792,485,000 in 2025 from RMB 5,767,215,000 in 2024, a decline of approximately 34.3%[112] - Interest income from bank deposits increased to RMB 155,149 in 2025, compared to RMB 194,314 in 2024, showing a decrease in interest earnings[56] - Interest income from bank deposits decreased to RMB 198,024 in 2025 from RMB 265,034 in 2024, reflecting a decline of approximately 25.3%[66] Taxation - The Group's subsidiaries in the PRC benefit from a preferential corporate income tax rate of 15% until December 31, 2030, due to their classification in encouraged industries[85] - The Group's overseas subsidiaries in the UK, Canada, and Chile did not incur any assessable income subject to local tax law during the year, resulting in no tax provisions for these jurisdictions[83] - The effect of preferential tax rates in 2025 was RMB 48,316,000, compared to RMB 606,101,000 in 2024, reflecting a decrease in tax benefits[79] - The tax effect of non-deductible expenses for 2025 was RMB 114,923,000, down from RMB 615,634,000 in 2024, indicating improved expense management[79] Market and Industry Trends - Lithium is primarily used in batteries (88%), with other applications including ceramics and glass (4%), lubricating greases (2%), and medical uses (1%)[138] - Since 2025, major economies have adjusted support measures for the new energy vehicle and energy storage industries, emphasizing supply chain security and energy storage[139] - China's policies are guiding the lithium battery industry towards a refined and sustainable growth model through resource management and capacity regulation[142] - New policies in China aim to establish a closed-loop management system for the lithium battery industry, enhancing resource circulation and reducing dependence on external resources[143] - The global focus of new energy policies is shifting towards a comprehensive system prioritizing energy storage and local manufacturing[141] Supply and Demand Dynamics - In 2025, global lithium resource supply is projected to reach approximately 1.767 million tons of LCE, representing a year-on-year increase of 20.1%[150] - Hard rock lithium resources are expected to contribute 1.205 million tons of LCE in 2025, accounting for about 68.2% of the total supply, with a year-on-year growth of 20.7%[150] - The demand for lithium salts and concentrates is expected to increase as downstream demand exceeds market expectations, shifting the industry outlook from temporary surplus to structural tightness[173] Price Trends - The price of spodumene concentrate (SC6.0) is expected to surpass $1,200 per ton by the end of 2025, continuing its upward momentum into early 2026[173] - Lithium carbonate prices exhibited a significant "decline followed by recovery" trend, with prices dropping below RMB 60,000 per ton before rebounding to over RMB 130,000 per ton in the second half of 2025, marking an increase of over 100%[192] - The most actively traded lithium carbonate futures contract on the Guangzhou Futures Exchange reached a low of RMB 58,400 to RMB 59,000 per ton in June 2025 before surging to RMB 134,500 per ton by December 29, 2025[199]

Financial Performance - For the fiscal year ending December 31, 2025, total revenue was SGD 46,276,000, a decrease of 7.8% from SGD 50,241,000 in 2024[4] - Gross profit for the fiscal year was SGD 7,189,000, down 37.5% from SGD 11,477,000 in the previous year[4] - The company reported a pre-tax loss of SGD 17,162,000, slightly improved from a loss of SGD 18,227,000 in 2024[4] - The total comprehensive loss for the year was SGD 16,448,000, compared to SGD 19,111,000 in 2024, indicating a reduction of 13.9%[5] - The company reported a total loss of SGD 17,395,000 for 2025, slightly improved from a loss of SGD 18,255,000 in 2024[12] - The group recorded a loss of SGD 17.4 million in FY2025, compared to a loss of SGD 18.3 million in FY2024, primarily due to decreased gross profit offset by reduced administrative expenses[34] Revenue and Growth - Revenue from customer contracts in China is expected to increase to SGD 29,989,000 in 2025 from SGD 25,927,000 in 2024, reflecting a growth of about 15.8%[11] - Sales from minimally invasive surgical solutions and related medical products increased by SGD 4.037 million to SGD 29.964 million in FY2025[27] - Revenue from minimally invasive surgical solutions and related services increased from SGD 25.9 million in FY2024 to SGD 30.0 million in FY2025, primarily due to growth in the Chinese market[28] - Revenue from labor dispatch and supporting services decreased from SGD 15.1 million in FY2024 to SGD 12.7 million in FY2025, attributed to a downturn in Singapore's dispatch and supporting services[28] Assets and Liabilities - Total assets increased to SGD 88,834,000 in 2025, up from SGD 58,867,000 in 2024, representing a growth of 50.9%[6] - Total liabilities increased to SGD 36,872,000, up from SGD 26,088,000, which is a rise of 41.2%[7] - The company’s equity attributable to owners increased to SGD 51,288,000 from SGD 31,806,000, a growth of 61.2%[6] - As of December 31, 2025, the group's total borrowings and lease liabilities were SGD 14.9 million, a slight increase from SGD 14.5 million in 2024, primarily due to loans from the parent company for operational purposes[44] Cash Flow and Financing - Cash and cash equivalents rose significantly to SGD 35,588,000 from SGD 10,446,000, marking an increase of 240.5%[6] - The group’s cash and cash equivalents as of December 31, 2025, totaled SGD 35.6 million, with 93% held in RMB, 1% in HKD, and 6% in SGD[45] - The company incurred total financing costs of SGD 675,000 in 2025, down from SGD 773,000 in 2024, a reduction of about 12.7%[12] - Financing costs slightly decreased by SGD 0.1 million in FY2025[32] Stock Options and Corporate Governance - The company has adopted a stock option plan approved by shareholders on December 29, 2023, allowing eligible participants to acquire ownership interests in the company[62] - A total of 128,603,750 stock options were granted on January 9, 2024, with an exercise price of HKD 2.54 per share, based on the highest of the closing price on the grant date or the average closing price over the previous five trading days[68] - The stock option plan has a maximum duration of 10 years, with a cap on the total number of shares that can be issued under the plan not exceeding 10% of the issued shares as of the special meeting date[64] - The company has adopted the corporate governance code and complied with all applicable provisions during the year[80] Risk Management - The company has implemented policies to minimize credit risk, including setting credit limits and conducting credit assessments before accepting new customers[57] - Trade receivables are evaluated at each reporting period to ensure adequate impairment losses are recognized, reflecting a significant reduction in credit risk[58] - The company maintains sufficient cash and cash equivalents to manage liquidity risk and reduce cash flow volatility[59] - The company faces fair value risk from financial assets and liabilities measured at fair value on a recurring and non-recurring basis[60] Future Plans and Investments - The group plans to allocate resources towards providing minimally invasive surgical solutions and related services, enhancing R&D capabilities, and expanding distribution networks[23] - The group plans to utilize the proceeds from the August 2025 placement, totaling HKD 161 million, for potential acquisitions in the healthcare sector and R&D expenses, with all funds expected to be used by the end of 2026[43] - The intended use of proceeds includes HKD 69 million for expanding the medical industry business, HKD 15 million for labor dispatch and supporting services, and HKD 15 million for general working capital[42] Employee and Operational Data - The group employed 485 staff members as of December 31, 2025, with total employee costs amounting to SGD 22.5 million for the fiscal year 2025[53] - The audit committee has reviewed the annual audited results and confirmed that the financial statements are prepared in accordance with applicable accounting standards and regulations[82] Miscellaneous - The company has not declared or paid any dividends for the years ending December 31, 2025, and 2024[17] - The group has no significant contingent liabilities as of December 31, 2025[48] - The company has no significant off-balance sheet transactions as of December 31, 2025[52] - The company expresses gratitude to all customers, management, employees, business partners, and shareholders for their continued support[86]

Financial Performance - For the year ending December 31, 2025, the group recorded a contracted sales amount of RMB 4.344 billion, a decrease of 35.4% compared to 2024[3] - The group's revenue for the year was RMB 9,792.3 million, down from RMB 33,416.9 million in 2024[4] - The loss attributable to equity holders of the parent company was RMB 17,439.9 million, compared to RMB 6,829.8 million in the previous year[3] - The net loss for the year was RMB 18,626.6 million, compared to RMB 7,539.0 million in the previous year[6] - The gross profit for the year was RMB 212.6 million, significantly lower than RMB 1,963.8 million in 2024[4] - The group reported a pre-tax loss of RMB 17,394,867 million for 2025, compared to a loss of RMB 6,829,835 million in 2024, indicating a deterioration in financial performance[36] - The group reported a loss of RMB 18,626.6 million in 2025, compared to a loss of RMB 7,539.0 million in 2024[71] Assets and Liabilities - As of December 31, 2025, the group had a total land reserve of 9.04 million square meters, down from 9.95 million square meters in 2024[3] - The total assets less current liabilities amounted to RMB (20,175.2 million), a decline from RMB 3,944.0 million in 2024[8] - The total liabilities for the group were RMB 106,284.3 million, slightly down from RMB 109,438.1 million in 2024[7] - As of December 31, 2025, the group had current liabilities of RMB 34,626,845,000 and total debt of RMB 59,202,314,000, with RMB 56,723,688,000 due within the next twelve months[12] - The group has significant contingent liabilities related to mortgage guarantees amounting to RMB 20,419.4 million as of December 31, 2025, compared to RMB 19,760.2 million on December 31, 2024[81] Cash Flow and Financing - The group's cash and cash equivalents decreased to RMB 688.1 million from RMB 1,215.3 million in 2024[7] - Cash and cash equivalents stood at RMB 688,054,000 as of December 31, 2025[12] - The group has defaulted on certain preferred notes totaling RMB 25,961,836,000 in principal and RMB 1,217,529,000 in interest, resulting in a default event of RMB 4,955,737,000[12] - The group is actively negotiating with lenders for the extension of repayment terms on certain loans[13] - The group is facing challenges in obtaining financing due to a decline in property pre-sales and ongoing difficulties in the capital market[79] Revenue Recognition - For the fiscal year 2025, the company reported customer contract revenue of RMB 9,713,671, a significant decrease from RMB 33,340,442 in fiscal year 2024, representing a decline of approximately 70.1%[25] - The company confirmed revenue from property sales at RMB 9,619,416 for the fiscal year 2025, down from RMB 30,178,205 in fiscal year 2024, indicating a decrease of about 68.1%[25][26] - The expected revenue to be recognized within one year from remaining performance obligations is RMB 4,431,240 for fiscal year 2025, compared to RMB 11,488,190 for fiscal year 2024, reflecting a decline of approximately 61.3%[28] - The total amount of remaining performance obligations expected to be recognized as revenue in one year and beyond is RMB 6,641,922 for fiscal year 2025, down from RMB 13,841,193 in fiscal year 2024, indicating a decrease of about 52.0%[28] Operational Strategy - The group aims to accelerate property sales as part of its business strategy and has measures in place to expedite the collection of receivables[13] - The group plans to focus on debt resolution and business transformation to achieve high-quality sustainable development in the upcoming year[44] - The company aims to enhance financial risk management and optimize asset structure to ensure financial stability[45] - The group will continue to improve product and service quality to win customer favor and enhance operational efficiency[45] Employee and Governance - The company had 499 employees as of December 31, 2025, down from 709 employees as of December 31, 2024[99] - The company has adopted a corporate governance code to ensure high standards of governance practices[112] - The board of directors includes executive directors Chen Jingde and Jin Mingjie, and non-executive director Zhou Weicheng, along with independent non-executive directors Wang Chuanxu, Xie Jun, and Yang Yongyi[123] Market Conditions and Risks - There is significant uncertainty regarding the group's ability to continue as a going concern, dependent on successful execution of its plans[14] - The group is actively monitoring foreign exchange fluctuations to protect its cash value, as it faces foreign exchange and interest rate risks[80] - The independent auditor's report indicates an inability to express an opinion on the consolidated financial statements due to significant uncertainties[116]

Financial Performance - The group's revenue decreased from approximately €29.5 million for the year ended December 31, 2024, to approximately €25.6 million for the year ended December 31, 2025, representing a decline of about 13.2%[4] - The gross profit margin decreased from approximately 36.4% for the year ended December 31, 2024, to approximately 35.9% for the year ended December 31, 2025[4] - The group recorded a loss attributable to equity holders of approximately €0.5 million for the year ended December 31, 2025, compared to a profit of approximately €15,000 for the year ended December 31, 2024[4] - The company reported a total comprehensive loss of €579,969 for the year ended December 31, 2025, compared to a total comprehensive loss of €6,209 for the year ended December 31, 2024[8] - The company reported a net loss attributable to shareholders of €(474,713) for 2025, compared to a profit of €15,297 in 2024[29] Revenue Breakdown - Total revenue for 2025 was €25,587,785, a decrease of 13.2% from €29,474,163 in 2024[17] - Revenue from home phones decreased to €14,892,626 in 2025 from €18,810,786 in 2024, representing a decline of 20.4%[17] - Revenue from office phones dropped by 48.7% to €2,115,931 in 2025 from €4,106,795 in 2024[17] - Revenue from France decreased by approximately 21.2% to about €11.6 million, accounting for approximately 45.4% of total revenue for the year ended December 31, 2025[45] - Revenue from other European countries decreased by approximately 14.0% to about €7.3 million, primarily due to a decline in home phone sales[45] - Revenue from the Asia-Pacific and Middle East regions increased by approximately 32.7% to about €5.4 million[46] - North America contributed approximately €0.9 million in revenue, accounting for 3.6% of total revenue for the year ended December 31, 2025[46] Expenses and Costs - The operating profit decreased significantly from €693,550 for the year ended December 31, 2024, to €27,760 for the year ended December 31, 2025[7] - Total expenses for sales, distribution, and administrative costs amounted to €25,440,520 in 2025, down from €28,804,941 in 2024[22] - Selling and distribution expenses decreased from approximately €4.0 million in 2024 to €3.7 million in 2025, mainly due to reduced freight and transportation costs[50] - Administrative expenses reduced from approximately €6.0 million in 2024 to €5.3 million in 2025, primarily due to a decrease in employee costs from company restructuring[51] Assets and Liabilities - The total assets decreased from €30.7 million as of December 31, 2024, to €26.3 million as of December 31, 2025[9] - The total liabilities decreased from €22.9 million as of December 31, 2024, to €19.1 million as of December 31, 2025[10] - The cash and cash equivalents decreased from €1.73 million as of December 31, 2024, to €0.98 million as of December 31, 2025[9] - The net debt-to-equity ratio increased to approximately 59% as of December 31, 2025, compared to 55% as of December 31, 2024, primarily due to an increase in shareholder loans[61] Dividends and Taxation - The company does not recommend the payment of any dividends for the year ended December 31, 2025[5] - The company has unrecognized tax losses of €326,284 in Hong Kong as of December 31, 2025, compared to €297,466 in 2024[27] - The effective tax rate for Hong Kong profits was maintained at 16.5% for both 2025 and 2024[23] Corporate Governance - The board held three formal meetings during the fiscal year, deviating from the corporate governance code which requires at least four meetings annually[68] - The audit committee consists of three independent non-executive directors, ensuring compliance with GEM listing regulations[74] - The company has adopted a code of conduct for directors' securities transactions, aligning with GEM listing rules[69] - The external auditor, KPMG, confirmed that the financial figures in the preliminary announcement align with the group's financial statements, although no audit opinion was issued[72] - The company has established an audit committee to oversee financial reporting procedures and internal control systems[73] - There were no reported conflicts of interest among directors, management, or major shareholders that could affect the group's business[70] Future Outlook - The company plans to assess the impact of new financial reporting standards effective from January 1, 2026, but does not expect significant effects on consolidated financial statements[15] - Revenue for 2025 is projected to decline compared to 2024, primarily due to a missed peak season in Europe, with a decrease of approximately 12.5% in sales costs from €18.8 million in 2024 to €16.4 million in 2025[48] - The company continues to focus on the elderly product market, expanding and improving its product range for individuals with vision and hearing impairments[48] - The announcement is in compliance with GEM listing rules and aims to provide accurate and complete information regarding Atlinks Group Limited[77] - The announcement will be available on the Hong Kong Stock Exchange website and the company's website for at least seven days from the publication date[77]

Financial Performance - For the fiscal year ending December 31, 2025, the group reported a revenue increase of 6.0% to approximately HKD 586.2 million[3]. - The group achieved a record profit of approximately HKD 93.3 million, representing a year-on-year growth of 12.7%, with a net profit margin increase of 1.0 percentage points to 15.9%[3]. - Earnings per share reached approximately HKD 1.56, reflecting a year-on-year growth of 15.5%, with a compound annual growth rate of 18.55% from 2023 to 2025[3]. - The company's revenue for the year ending December 31, 2025, was HKD 552,980,000, representing a 6.0% increase from HKD 586,211,000 in the previous year[6]. - Gross profit amounted to HKD 461,068,000, reflecting a 5.7% increase compared to HKD 487,561,000 in the prior year[6]. - The total income from other sources was HKD 8,885,000, which is a 16.3% increase from HKD 10,336,000 in the previous year[6]. - The company reported a net profit of HKD 82,774,000 for the year, which is a 12.7% increase from HKD 93,327,000 in the previous year[6]. - The group recorded revenue of approximately HKD 586.2 million for the year, representing a year-on-year growth of 6.0%[68]. - The group achieved a record profit of approximately HKD 93.3 million, a significant year-on-year increase of 12.7%, with a net profit margin rising by 1.0 percentage point to 15.9%[56]. - Earnings per share reached approximately HKD 1.56, reflecting a year-on-year growth of 15.5%, with a compound annual growth rate of 18.55% from 2023 to 2025[56]. Cash Flow and Liquidity - Operating cash flow and free cash flow increased by 32.7% and 27.3% respectively, with a cash ratio rising from 0.53 times at the end of 2024 to 1.63 times at the end of 2025[3]. - The cash conversion cycle improved from 124 days to 107 days, indicating enhanced operational efficiency[14]. - Cash and cash equivalents amounted to approximately HKD 122.9 million, with a cash ratio rising from 0.53 times at the end of 2024 to 1.63 times at the end of 2025[79]. - The company reported a significant increase in cash flow from operations, contributing to improved liquidity and financial stability[140]. Research and Development - The group’s R&D expenses decreased by 23.9% to approximately HKD 39.8 million, reflecting the completion of several key project milestones[55]. - The company is advancing a transformative R&D pipeline covering four key areas: musculoskeletal regeneration, skin regeneration, ophthalmic regeneration, and ENT regeneration[26]. - The company plans to increase R&D expenses in 2026, targeting a ratio of at least 9% of total revenue, with key initiatives including advancing the registration and commercialization of Uni-PTH in the US market[74]. - Research and development expenses for 2025 amounted to HKD 44,944,000, a decrease from HKD 54,694,000 in 2024, indicating a reduction of about 17.8%[159]. Product Development and Market Expansion - The group received approval for its second ophthalmic product "金因康®" in May 2025, marking a significant milestone in expanding its ophthalmic product portfolio[4]. - The launch of the high-end series "GeneQueens®" and the medical device brand "金因敷®" in June 2025 signifies the company's entry into the integrated fields of pharmaceuticals, medical devices, and medical aesthetics[4]. - The product "博固泰®" recorded a significant revenue growth of 111.0% in China, highlighting strong local demand for innovative osteoporosis treatments[18]. - The company is actively exploring the combination of BMP-2 with stem cell technology for regenerative therapy, showing significant efficacy in diseases like diabetic foot and knee osteoarthritis[37]. - The company is developing advanced skincare ingredients, including collagen and beauty peptides, with a focus on safety and efficacy, leveraging partnerships for rapid commercialization[43]. Strategic Partnerships and Collaborations - A strategic partnership was established with Wenzhou Medical University to co-develop a thermosensitive gel formulation combining EGF and bFGF, enhancing regenerative medicine capabilities[4]. - The group signed a tripartite strategic cooperation agreement with Wenzhou Medical University to enhance capabilities in regenerative medicine, focusing on innovative therapies driven by growth factors[102]. - A collaboration agreement has been established with GBB and TigerMed Pebble Accelerator to jointly develop innovative weight loss drugs, leveraging AI technology for molecular screening[38]. Market Trends and Projections - The Chinese pharmaceutical market is projected to grow from USD 240.8 billion in 2024 to USD 460.9 billion by 2035, with a compound annual growth rate (CAGR) of 6.1%[7]. - The global regenerative medicine market is projected to grow from approximately USD 63 billion in 2026 to USD 555.6 billion by 2034, with a compound annual growth rate of 31.3%[81]. - The medical beauty services market is expected to reach RMB 370.1 billion in 2025, driven by increased demand for safe and effective products targeting specific skin issues[9]. Shareholder Returns and Dividends - The board proposed a final dividend of HKD 0.313 per share, reflecting a balanced capital distribution approach while maintaining financial flexibility for future investments[14]. - The company has proposed a final dividend of HKD 0.313 per share for the year ending December 31, 2025, up from HKD 0.277 per share for the year ending December 31, 2024, which is an increase of about 13%[165]. Operational Efficiency - Selling and distribution expenses were approximately HKD 292.0 million, an increase of 11.6% from approximately HKD 261.6 million in the previous year, accounting for 49.8% of revenue[73]. - The company has maintained sufficient liquidity despite the loan arrangements and believes the terms of the extensions are fair and reasonable[125]. - The company has confirmed that the loan extensions do not significantly impact its operational and financial performance[125].

Financial Performance - Dongguan Rural Commercial Bank reported a net profit of RMB 39.1 million, which is 10% of the audited annual profit allocated to statutory surplus reserves[11]. - The bank plans to distribute a cash dividend of RMB 0.22 per share, subject to approval at the 2025 annual general meeting[11]. - The bank achieved an operating income of RMB 11.697 billion and a net profit of RMB 3.877 billion, with a non-performing loan ratio of 1.79% and a provision coverage ratio of 207.68%[28]. - Total operating revenue for 2025 was RMB 11,696,578, a decrease of 5.00% compared to 2024[40]. - Pre-tax profit for 2025 was RMB 3,731,794, down 9.07% from the previous year[40]. - Net profit for 2025 was RMB 3,876,823, reflecting a decline of 20.24% year-over-year[40]. - The average return on total assets for 2025 was 0.50%, down from 0.67% in 2024[44]. - The net interest margin for 2025 was 1.19%, a decrease from 1.30% in 2024[44]. - The total equity of the group was RMB 63.02 billion, an increase of RMB 0.56 billion or 0.89% from the previous year[114]. Assets and Liabilities - As of the end of 2025, Dongguan Rural Commercial Bank's total assets reached RMB 796.016 billion, with total deposits of RMB 544.212 billion and total loans of RMB 409.031 billion[28]. - The total liabilities of the group reached RMB 732.99 billion, an increase of RMB 49.55 billion or 7.25% compared to the end of the previous year[108]. - Customer deposits amounted to RMB 554.21 billion, up RMB 23.96 billion or 4.61% year-on-year, with individual deposits accounting for 60.20% and corporate deposits for 37.70%[110]. - The issued debt securities increased to RMB 114.90 billion, representing 15.68% of total liabilities, compared to 12.22% the previous year[109]. - The total amount of customer loans and advances reached RMB 409.03 billion, an increase of RMB 27.99 billion or 7.34% compared to the end of the previous year[120]. Loan Portfolio - The group reported a loan balance of 60.047 billion RMB for technology enterprises, with a growth rate of 26.92%[20]. - The balance of inclusive loans for small and micro enterprises was 54.166 billion RMB, with a growth rate of 7.08%[20]. - The group supported 1,123 national and provincial "specialized, refined, distinctive, and innovative" enterprises, with a loan growth rate of 17.05% in manufacturing and related industries[21]. - The non-performing loan (NPL) balance was RMB 72.92 billion, an increase of RMB 3.15 billion, with an NPL ratio of 1.79%, a decrease of 0.05 percentage points from the previous year[123]. - Corporate loans accounted for 60.28% of total loans, with a total amount of RMB 246.55 billion and an NPL ratio of 1.51%[128]. - Personal loans totaled RMB 126.53 billion, representing 30.93% of total loans, with an NPL ratio of 2.85%[128]. Risk Management - The board of directors confirmed that there are no significant risks affecting the bank's future development strategy and operational goals[11]. - The bank's management discussion and analysis section details the main risks faced and the measures taken to address them[11]. - The group has established a comprehensive liquidity risk management structure involving the board, supervisory board, senior management, and various departments[200]. - The overall credit risk is under control, with the non-performing loan ratio maintained within management targets[198]. - The group has implemented standardized credit review and approval processes to enhance credit risk management[198]. Digital Transformation and Innovation - The bank's development strategy focuses on digital transformation and light capital development, aiming to become a regional value-oriented rural commercial bank group[30][31]. - The group is advancing its digital transformation strategy, integrating data elements and digital technologies into all operational management aspects[186]. - The group aims to enhance risk management capabilities by developing an intelligent risk control system that covers the entire business process[190]. - The group has completed the local deployment and optimization of open-source large models for AI applications in risk control and customer service[189]. Awards and Recognition - The bank has received multiple awards, including the Dongguan City Contribution Award for 2024 and recognition for its green finance initiatives[33]. Future Outlook - The outlook for 2026 emphasizes adherence to the central financial work conference's spirit and enhancing value creation capabilities[22].

Financial Performance - Total revenue for the year ended December 31, 2025, was RMB 2,006.74 million, a decrease of 7.54% from RMB 2,170.99 million in 2024[2] - Aviation business revenue was RMB 1,069.95 million, slightly down from RMB 1,081.10 million in 2024[2] - Non-aviation business revenue decreased to RMB 936.79 million from RMB 1,089.89 million in 2024, representing a decline of 14.05%[2] - Net loss for 2025 was RMB 274.56 million, an improvement from a net loss of RMB 366.25 million in 2024[2] - Loss attributable to equity holders of the parent was RMB 279.00 million, compared to RMB 381.44 million in the previous year[2] - Total revenue for the fiscal year 2025 was RMB 2.007 billion, a decrease of 7.5% compared to RMB 2.171 billion in 2024[13] - Revenue from passenger service fees was RMB 515 million, up from RMB 503 million in 2024, indicating a growth of 2.4%[13] - The company reported a significant decrease in non-aeronautical revenue, which fell to RMB 937 million from RMB 1.090 billion, a decline of 14%[13] - The company's net loss for the fiscal year 2025 was RMB 275 million, with a net cash inflow from operating activities of RMB 438 million[10] Operational Metrics - Passenger throughput reached 26.85 million, indicating a recovery in travel demand[3] - The number of aircraft movements was 185,220, reflecting operational stability[3] - Cargo and mail throughput was 215,752.30 tons, showing resilience in logistics operations[3] - The total passenger throughput for 2025 was 2,685.11 million, a slight decrease of 0.15% from 2,689.04 million in 2024, with international passenger numbers increasing by 27.63%[24] - The number of operating routes increased to 296 in 2025, with 86 new routes launched, including 60 domestic and 20 international passenger routes[23] Assets and Liabilities - Total assets decreased to RMB 9,918.30 million from RMB 10,982.58 million in 2024, indicating a reduction in overall asset base[6] - Cash and cash equivalents dropped to RMB 282.18 million from RMB 541.08 million in 2024, highlighting liquidity challenges[6] - As of December 31, 2025, the company's current liabilities amounted to RMB 3.449 billion, exceeding current assets of RMB 2.789 billion[11] - The total liabilities of the company as of December 31, 2025, were RMB 6.116 billion, a decrease from RMB 6.931 billion in 2024[10] - The company's total assets minus current liabilities stood at RMB 6.470 billion as of December 31, 2025[11] Shareholder Information - As of December 31, 2025, the total issued share capital is 473,213,000 shares, with 52% being domestic shares and 48% H-shares[70] - Major shareholders include Hainan Airport Facilities Co., Ltd., holding 96.43% of domestic shares, equating to 50.19% of total share capital[72] - M&G Plc holds 15.00% of H-shares, representing 7.19% of total share capital[73] Corporate Governance - The audit committee has reviewed the company's financial statements for the year ended December 31, 2025, and found no disagreement with the accounting policies adopted[79] - The board of directors includes four independent non-executive directors, and the audit committee is composed of three independent non-executive directors, two of whom have accounting professional qualifications[80] - The company has adopted a code of conduct for securities transactions by directors and supervisors that meets or exceeds the standards set by the relevant guidelines[81] - The company is committed to complying with all regulations set by the China Securities Regulatory Commission and the Hong Kong Stock Exchange, continuously improving its corporate governance structure[82] - The chairman and CEO roles are held by the same individual, Mr. Wang Hong, which deviates from the corporate governance code, but the board believes this arrangement ensures effective leadership[83] Future Plans and Strategies - The company plans to enhance its domestic route network and expand international routes to Central Asia, India, and Europe, aiming for a steady improvement in the international aviation market[60] - The company will focus on safety development and upgrade its safety management system, emphasizing sustainable safety practices and technology empowerment projects[61] - The company aims to optimize cost efficiency through measures such as energy conservation, tax reductions, and improved management efficiency[59] - The company will continue to deepen reforms and open up in Hainan Free Trade Port, aiming for high-quality development during the 14th Five-Year Plan period[58] - The company anticipates that the global economy will face uncertainties but expects new opportunities from technological advancements and strong resilience in the Chinese economy[57] Awards and Recognition - The company received 9 awards in 2025 for service quality, including the 13th National Brand Story Contest Potential Award from the China Quality Association[52] Employment and Contributions - As of December 31, 2025, the company employed 4,115 people, a decrease of 74 employees year-on-year[54] - The company's pension contributions for the year ending December 31, 2025, amounted to RMB 101,044,295, compared to RMB 96,931,349 in 2024, reflecting an increase of approximately 4.5%[55] Operational Enhancements - The new data platform at Meilan Airport has integrated data from 35 systems, providing standardized data services to 16 downstream systems, with over 2.1 million data entries processed daily[45] - The introduction of new intelligent systems at Meilan Airport has significantly improved operational efficiency, including the smart financial management system and the intelligent position management system[46] - The airport's new automated broadcasting system enhances passenger service experience through precise multi-area broadcasting capabilities[46] Debt Management - The group has actively optimized its debt structure, resulting in a decrease in financial expenses to RMB 102,302,420, down RMB 31,948,927 year-on-year[33] - As of December 31, 2025, the group had cumulative principal of RMB 4.859 billion from the new syndicated loan, with RMB 2.12 billion repaid[39] - The group has no significant contingent liabilities other than the arrangements for the new syndicated loan as of December 31, 2025[43] Miscellaneous - The company will not distribute a final dividend for the year ending December 31, 2025, due to significant funding needs for strategic developments[66] - There are no significant litigations or arbitrations reported as of December 31, 2025[69] - The company or any of its subsidiaries did not purchase, sell, or redeem any listed securities of the company during the year ended December 31, 2025[78] - The annual report for the year 2025 will be published by April 28, 2026, and will be available on the Hong Kong Stock Exchange website and the company's website[84]

Financial Performance - For the year ending December 31, 2025, the company reported a revenue of RMB 7,187.7 million, a decrease of 5.1% year-on-year, primarily due to delays in the procurement of Class A large medical equipment affecting nuclear medical equipment revenue[4]. - Net profit for the year was RMB 664.5 million, down 24.4% year-on-year, while profit attributable to equity shareholders was RMB 327.4 million, a decrease of 19.5%[4]. - The company's operating profit for 2025 was RMB 1,058.6 million, compared to RMB 1,086.4 million in 2024, reflecting a slight decline[5]. - The company reported a total comprehensive income of RMB 662.3 million for the year, compared to RMB 875.5 million in 2024, reflecting a decline in overall profitability[6]. - The total revenue for the group in 2025 was RMB 7,187,661,000, a decrease from RMB 7,574,756,000 in 2024, representing a decline of approximately 5.1%[14]. - The group reported a gross profit of RMB 3,621,598,000 for 2025, compared to RMB 3,682,832,000 in 2024, showing a decrease of about 1.7%[21]. - Gross profit fell by 1.7% from RMB 3,682.8 million in 2024 to RMB 3,621.6 million in 2025, while gross margin improved from 48.6% to 50.4% due to enhanced cost control measures[82]. - Net profit decreased by 24.4% from RMB 879.5 million in 2024 to RMB 664.5 million in 2025[91]. Dividends and Shareholder Returns - The board proposed a final cash dividend of RMB 0.2264 per share (tax included), in addition to an interim dividend of RMB 0.0807 per share for the year 2025[4]. - Proposed final dividend per share for 2025 is RMB 0.2264, a decrease from RMB 0.309 in 2024, representing a reduction of 27%[30]. - The company has a dividend policy that includes a mandatory allocation of 10% of after-tax profits to statutory reserves, with the remaining profits distributed to shareholders based on their shareholdings[107]. - The company’s cash dividends for domestic shareholders are declared in RMB and paid in RMB, while H-share dividends are declared in RMB and paid in HKD[108]. - The company’s board of directors considers various factors, including operational performance and future prospects, when deciding on dividend distributions[109]. - The board has proposed a final dividend of RMB 0.2264 per share for the year ending December 31, 2025, totaling RMB 72,419,677.36[129]. Assets and Liabilities - Total assets as of December 31, 2025, amounted to RMB 10,425.4 million, an increase from RMB 9,743.9 million in 2024[7]. - Non-current liabilities increased to RMB 2,291.9 million in 2025 from RMB 1,999.4 million in 2024, indicating a rise in long-term financial obligations[8]. - The total equity attributable to equity shareholders was RMB 5,226.8 million, up from RMB 5,005.3 million in 2024[8]. - Total assets increased to RMB 15,716.3 million as of December 31, 2025, while total liabilities amounted to RMB 7,582.8 million[92]. - Current assets increased to RMB 9,335.6 million in 2025 from RMB 8,918.3 million in 2024, with a current asset net value rising by 3.8% to RMB 4,044.7 million[95]. Research and Development - Research and development expenses for the year were RMB 301.9 million, slightly up from RMB 300.3 million in 2024[5]. - The company is conducting Phase III clinical trials for six nuclear medicines, including lutetium-177 oxaliplatin injection, and has received approval for clinical trials of boron neutron capture therapy drugs[48]. - The company is developing diagnostic drugs for various cancers, including iodine-131 MIBG for neuroendocrine tumors and fluorine-18 Florastamin for prostate cancer, with ongoing Phase III clinical trials[50]. - The company is advancing diagnostic drugs for neurodegenerative diseases, including fluorine-18 Florbetazine for Alzheimer's disease and fluorine-18 L-DOPA for Parkinson's disease, both entering Phase III clinical trials[51]. - The group is conducting Phase III clinical trials for the 68Ga-DOTATATE and 177Lu-DOTATATE products, which are expected to significantly improve diagnostic and treatment efficiency for neuroendocrine tumors[53]. Operational Highlights - The company has established numerous research collaborations with leading institutions and universities to strengthen academic exchange and talent cultivation in the field of radioactive pharmaceuticals[58]. - The company has implemented an ERP system across nine units and is advancing digital transformation initiatives to enhance operational efficiency and data management[59]. - The company has expanded its national network of pharmaceutical centers, with 29 centers now operational, including new production lines in Guiyang and Urumqi[62]. - The company has successfully commercialized the "Radiant Intelligence 1.0" smart nuclear medicine system, completing six project signings in 2025, marking a significant market validation[65]. - The company has initiated the development of the "Radiant Intelligence 2.0" system, supported by funding from the Beijing Science and Technology Commission, to enhance digital and standardized management in nuclear medicine[67]. Market and Strategic Initiatives - The company is actively expanding its international collaborations and has secured exclusive agency rights for the new medical radioactive isotope Thallium-161, indicating a key breakthrough in domestic production and market application[44]. - The company signed new contracts for radiation stations in Peru and Bangladesh in 2025 and established a memorandum of understanding with Brazil's National Nuclear Energy Commission, marking significant breakthroughs in international business[47]. - The market development strategy includes a three-pronged approach of brand promotion, channel construction, and after-sales service, focusing on both consolidating existing markets and expanding new ones[71]. - The group will strengthen international market presence, particularly in South America, Southeast Asia, the Middle East, North Africa, and countries along the Belt and Road Initiative, promoting core products for large-scale export[72]. Risk Management - Major risks identified include operational, investment, market, interest rate, and liquidity risks, with management strategies in place to mitigate these risks[74][75][76][77][78][79]. - The company has established policies to continuously monitor credit risk, focusing on customer reputation and credit quality assessments before accepting new clients with significant credit amounts[105]. - The company has no significant liquidity risk due to sufficient cash reserves and commitments from major financial institutions to meet short-term and long-term liquidity needs[106]. Corporate Governance - The company is committed to enhancing corporate governance and has adopted the principles of the Corporate Governance Code[122]. - The audit and risk management committee has reviewed the consolidated financial performance for the year ending December 31, 2025[124]. - The board of directors includes both executive and non-executive members, ensuring a diverse governance structure[133].